Chemotherapy in alimentary tract malignomas.
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002330:Carmustine / Q000627:therapeutic use; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000401:mortality; D003561:Cytarabine / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D008130:Lomustine / Q000627:therapeutic use; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D016685:Mitomycin; D008937:Mitomycins / Q000627:therapeutic use; D012004:Rectal Neoplasms / Q000188:drug therapy* / Q000401:mortality; D012673:Semustine / Q000627:therapeutic use; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000401:mortality; D013311:Streptozocin / Q000627:therapeutic use; D005641:Tegafur / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D008937:Mitomycins; D003561:Cytarabine; D012673:Semustine; D005641:Tegafur; D016685:Mitomycin; D014750:Vincristine; D013311:Streptozocin; D008130:Lomustine; D004317:Doxorubicin; D005472:Fluorouracil; D002330:Carmustine; D008727:Methotrexate